SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.

Casadevall, Arturo; Henderson, Jeffrey P; Joyner, Michael J; Pirofski, Liise-Anne

Casadevall, Arturo; Henderson, Jeffrey P; Joyner, Michael J; Pirofski, Liise-Anne.

Casadevall A; Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
Henderson JP; Departments of Medicine and Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Joyner MJ; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Pirofski LA; Departments of Medicine and Microbiology and Immunology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.

J Clin Invest ; 131(7)2021 04 01.

Article in English | MEDLINE | ID: covidwho-1666527

Subject(s)

COVID-19/therapy; COVID-19/virology; SARS-CoV-2/immunology; Antibodies, Neutralizing/biosynthesis; Antibodies, Neutralizing/blood; Antibodies, Viral/biosynthesis; Antibodies, Viral/blood; COVID-19/immunology; Genome, Viral; Host Microbial Interactions/immunology; Humans; Immune Evasion; Immunization, Passive/adverse effects; Models, Immunological; Pandemics; SARS-CoV-2/genetics; SARS-CoV-2/pathogenicity; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Variants Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Jci148832

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google